Pulmonx Corp
Ownership
Ownership Structure
Who owns Pulmonx Corp (LUNG)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 87.6% of the shares are freely tradable; institutional investors hold 79.1%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| PRIMECAP Management Company | 10.74 | 4,612,331 | -2.4 | 06/30/2026 |
| Morgan Stanley - Brokerage Accounts | 9.30 | 3,993,562 | -4.0 | 03/31/2026 |
| Soleus Capital Management, L.P. | 6.49 | 2,788,323 | +0.0 | 06/30/2026 |
| BlackRock Inc | 6.20 | 2,661,607 | -1.6 | 03/31/2026 |
| ExodusPoint Capital Management, LP | 4.53 | 1,943,834 | -0.4 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.81 | 1,634,264 | +0.0 | 03/31/2026 |
| Bank of America Corp | 2.72 | 1,166,826 | +60.3 | 03/31/2026 |
| Deutsche Bank AG | 2.71 | 1,163,678 | +3.4 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| PRIMECAP Odyssey Aggressive Growth | 8.39 | 3,602,001 | +0.0 | 06/30/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.68 | 1,152,272 | +0.0 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| French Glendon E. III | President and CEO | 1,137,936 | 2,389,666 $ | Sep 1, 2026 | direct |
| Rose Geoffrey Beran | Chief Commercial Officer | 449,832 | 944,647 $ | Sep 1, 2026 | direct |
| Lehman David Aaron | General Counsel | 361,827 | 759,837 $ | Sep 1, 2026 | direct |
| Radhakrishnan Srikanth | Chief Science & Techn. Officer | 316,994 | 665,687 $ | Sep 1, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Radhakrishnan Srikanth | Chief Science & Techn. Officer | Sell | 5,863 | 2.26 | 13,250 |
| Sep 1, 2026 | Radhakrishnan Srikanth | Chief Science & Techn. Officer | Sell | 3,618 | 2.26 | 8,177 |
| Sep 1, 2026 | Radhakrishnan Srikanth | Chief Science & Techn. Officer | Sell | 2,121 | 2.26 | 4,793 |
| Sep 1, 2026 | Radhakrishnan Srikanth | Chief Science & Techn. Officer | Sell | 2,643 | 2.26 | 5,973 |
| Sep 1, 2026 | French Glendon E. III | President and CEO | Sell | 37,784 | 2.26 | 85,392 |
| Sep 1, 2026 | French Glendon E. III | President and CEO | Sell | 4,098 | 2.26 | 9,261 |
| Sep 1, 2026 | Rose Geoffrey Beran | Chief Commercial Officer | Sell | 1,746 | 2.26 | 3,946 |
| Sep 1, 2026 | Rose Geoffrey Beran | Chief Commercial Officer | Sell | 1,530 | 2.26 | 3,458 |
| Sep 1, 2026 | Rose Geoffrey Beran | Chief Commercial Officer | Sell | 2,390 | 2.26 | 5,401 |
| Sep 1, 2026 | Rose Geoffrey Beran | Chief Commercial Officer | Sell | 2,213 | 2.26 | 5,001 |
| Sep 1, 2026 | Lehman David Aaron | General Counsel | Sell | 4,827 | 2.26 | 10,909 |
| Sep 1, 2026 | Lehman David Aaron | General Counsel | Sell | 3,476 | 2.26 | 7,856 |
| Sep 1, 2026 | Lehman David Aaron | General Counsel | Sell | 2,224 | 2.26 | 5,026 |
| Sep 1, 2026 | Lehman David Aaron | General Counsel | Sell | 3,807 | 2.26 | 8,604 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.